Category Ranking

98%

Total Visits

921

Avg Visit Duration

2 minutes

Citations

20

Article Abstract

Cadmium, a toxic heavy metals that would cause lung tissue damage and structural alterations via oxidative stress and inflammatory responses. This study was designed to investigate the protective function and its potential mechanism of quercetin against cadmium-induced acute lung injury. Rat and BEAS-2B cell models of CdCl-induced ALI were established, and the apoptotic and proliferative activities of tissue cells, inflammatory factors such as TNF-α, IL-6, and IL-1β, and the expression of key proteins in the Nrf2-Keap1 pathway, mitochondrial pathway, and mitochondrial membrane potential were examined using Immunohistochemistry, TUNEL, CCK8, ELISA, Western blot, and flow cytometry to evaluate the therapeutic effect of quercetin. Quercetin significantly alleviated CdCl-induced pulmonary edema, tissue damage and inflammatory response, and inhibited lung cell apoptosis in rats. It increased the expression of antioxidant enzyme genes, reduced ROS generation, restored Redox Equilibrium, and protected mitochondrial function by the Nrf2-Keap1 signaling pathway activation. In addition, quercetin also exhibited inhibitory effects on CdCl-induced apoptosis in BEAS-2B cells in vitro. Quercetin significantly attenuated cadmium-induced acute lung injury through antioxidant stress and protection of mitochondrial function, and has potential therapeutic value for acute lung injury.

Download full-text PDF

Source
http://dx.doi.org/10.1002/jbt.70463DOI Listing

Publication Analysis

Top Keywords

acute lung
16
lung injury
16
cadmium-induced acute
12
nrf2-keap1 pathway
8
pathway activation
8
tissue damage
8
function potential
8
pathway mitochondrial
8
mitochondrial function
8
quercetin
6

Similar Publications

Acute lung injury (ALI) is a major contributor to the high morbidity and mortality associated with intestinal ischemia-reperfusion (II/R). Despite its severity, current clinical management of ALI remains limited to supportive care without addressing the cause of the disease, underscoring the urgent need to investigate the underlying mechanism and develop targeted therapies. In this study, we employed both in vitro and in vivo models to explore ALI in the setting of II/R.

View Article and Find Full Text PDF

Objective: To develop a natural language processing (NLP) pipeline for unstructured electronic health record (EHR) data to identify symptoms and functional impacts associated with Long COVID in children.

Materials And Methods: We analyzed 48 287 outpatient progress notes from 10 618 pediatric patients from 12 institutions. We evaluated notes obtained 28 to 179 days after a COVID-19 diagnosis or positive test.

View Article and Find Full Text PDF

Introduction  Chronic Obstructive Pulmonary Disease (COPD) is increasingly recognized not only as a pulmonary condition but as a systemic disorder with significant cardiovascular implications. Acute exacerbations of COPD (AECOPD) further elevate this risk, potentially through a heightened prothrombotic state. This study aimed to evaluate and compare the levels of select prothrombotic biomarkers - fibrinogen, C-reactive protein (CRP), D-dimer, von Willebrand Factor (vWF), homocysteine, lactate dehydrogenase (LDH), and platelet-to-lymphocyte ratio (PLR) - in patients with stable COPD and AECOPD, and to assess their diagnostic and prognostic significance.

View Article and Find Full Text PDF

Immune reconstitution inflammatory syndrome (IRIS) is commonly described in individuals recovering from immunosuppression, particularly in HIV-positive patients initiating antiretroviral therapy. However, a similar rebound phenomenon can occur postpartum, a period marked by a shift from an immunotolerant to a pro-inflammatory state. IRIS in this context is underrecognized and may present atypically, complicating timely diagnosis.

View Article and Find Full Text PDF

 is a protozoan parasite that typically causes self-limited diarrhea in healthy individuals but can result in prolonged, severe illness in those who are immunocompromised. While this infection is well recognized in HIV-positive patients, it is less frequently reported in individuals with lupus nephritis on immunosuppressive therapy. We report the case of a 27-year-old man with biopsy-confirmed class IV lupus nephritis who was receiving cyclophosphamide and corticosteroids.

View Article and Find Full Text PDF